Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by China Sxt Pharmaceuticals, Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -10.53% vs -5.00% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -6.45% vs 47.46% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.70",
          "val2": "1.90",
          "chgp": "-10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-1.90",
          "chgp": "15.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.50",
          "chgp": "20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "-0.40",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.30",
          "val2": "-3.10",
          "chgp": "-6.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-961.80%",
          "val2": "-1,084.90%",
          "chgp": "12.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1.70

1.90

-10.53%

Operating Profit (PBDIT) excl Other Income

-1.60

-1.90

15.79%

Interest

0.60

0.50

20.00%

Exceptional Items

-1.00

-0.40

-150.00%

Consolidate Net Profit

-3.30

-3.10

-6.45%

Operating Profit Margin (Excl OI)

-961.80%

-1,084.90%

12.31%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -10.53% vs -5.00% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -6.45% vs 47.46% in Mar 2024

All Annual Results